GlucoModicum Reports Positive Clinical Results with its Needle-Free CGM and Advances Toward Market Launch Comprehensive clinical performance study encompassed 646 participant visits, including both ...

Learn how in vitro diagnostic (IVD) devices can comply with IVDR and Indian MDR standards, ensuring regulatory alignment, ...

Mechelen, Belgium, 02 June 2025 – Biocartis NV (“Biocartis”), an innovative molecular diagnostics company, is pleased to announce that its Idylla™ EGFR Mutation Test has received the European Union ...

Global Cystatin C Assay Market is valued at approximately USD 350.70 million in 2022 and is anticipated to grow with a healthy growth rate of more than 7.5% during the forecast period 2023-2030. Read ...

Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and ...

Under IVDR, manufacturers must generate a cumbersome amount of data, which is a real challenge in a world where clinical guidelines and best practices can change frequently and rapidly.

Revolutionary Platform Sets New Benchmark for Transparency and Compliance in Diagnostic AI As the May 26th CE-IVDR compliance deadline comes into effect, Diagnostics.ai launches the industry’s ...

Invivoscribe's subsidiary, LabPMM, has secured New York State (NYS) approval for the NPM1 MRD Assay to combat acute myeloid ...